Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 05, 2015 4:47 AM ET


Company Overview of KaloBios Pharmaceuticals, Inc.

Key Executives for KaloBios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Herbert C. Cross No RelationshipsInterim Chief Executive Officer, Interim President and Chief Financial Officer43
Ronald A. Martell 46 RelationshipsExecutive Chairman53
Charles J. Democko No RelationshipsSenior Vice President of Regulatory Affairs and Quality60

KaloBios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Ronald A. Martell 46 RelationshipsKaloBios Pharmaceuticals, Inc.53
James W. Larrick Ph.D. 42 RelationshipsKaloBios Pharmaceuticals, Inc.--
Raymond M. Withy Ph.D. 7 RelationshipsKaloBios Pharmaceuticals, Inc.60
Denise M. Gilbert Ph.D. 7 RelationshipsKaloBios Pharmaceuticals, Inc.57
Gary A. Lyons 37 RelationshipsRigel Pharmaceuticals, Inc.64
View All Board Members

KaloBios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Ph.D.Denise M. Gilbert7 Relationships3 Executives
Compensation Committee Gary A. Lyons37 Relationships3 Executives
Nominating Committee Ph.D.Raymond M. Withy7 Relationships3 Executives
Corporate Governance Committee Ph.D.Raymond M. Withy7 Relationships3 Executives
Advisory Board Ph.D.James W. Larrick42 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$340.0K
Compensation as of Fiscal Year 2014
KaloBios Pharmaceuticals, Inc. CEO Compensation
Industry Average


SC Johnson Appoints Ann Mukherjee as Global Chief Marketing Officer
October 02, 2015 12:00 AM ET
Spectrum Brands Holdings, Inc. Announces Changes to the Board of Directors
September 28, 2015 12:00 PM ET
Mary Agnes Wilderotter Does Not Stand for Re-Election to Board of Directors of The Procter & Gamble Company
September 25, 2015 8:00 PM ET
The National Detergent Company S.A.O.G. Announces Board Changes
September 21, 2015 7:50 AM ET
Procter & Gamble Announces Retirement of Tarek Farahat as President of Latin America Selling and Market Operations
September 18, 2015 4:32 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KaloBios Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at